Correlation Between Cardiff Oncology and Intercept Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cardiff Oncology and Intercept Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cardiff Oncology and Intercept Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cardiff Oncology and Intercept Pharmaceuticals, you can compare the effects of market volatilities on Cardiff Oncology and Intercept Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cardiff Oncology with a short position of Intercept Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cardiff Oncology and Intercept Pharmaceuticals.

Diversification Opportunities for Cardiff Oncology and Intercept Pharmaceuticals

-0.3
  Correlation Coefficient

Very good diversification

The 3 months correlation between Cardiff and Intercept is -0.3. Overlapping area represents the amount of risk that can be diversified away by holding Cardiff Oncology and Intercept Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Intercept Pharmaceuticals and Cardiff Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cardiff Oncology are associated (or correlated) with Intercept Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Intercept Pharmaceuticals has no effect on the direction of Cardiff Oncology i.e., Cardiff Oncology and Intercept Pharmaceuticals go up and down completely randomly.

Pair Corralation between Cardiff Oncology and Intercept Pharmaceuticals

Given the investment horizon of 90 days Cardiff Oncology is expected to generate 5.22 times more return on investment than Intercept Pharmaceuticals. However, Cardiff Oncology is 5.22 times more volatile than Intercept Pharmaceuticals. It trades about 0.07 of its potential returns per unit of risk. Intercept Pharmaceuticals is currently generating about -0.75 per unit of risk. If you would invest  149.00  in Cardiff Oncology on September 12, 2024 and sell it today you would earn a total of  229.00  from holding Cardiff Oncology or generate 153.69% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy1.14%
ValuesDaily Returns

Cardiff Oncology  vs.  Intercept Pharmaceuticals

 Performance 
       Timeline  
Cardiff Oncology 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Cardiff Oncology are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite nearly inconsistent fundamental indicators, Cardiff Oncology reported solid returns over the last few months and may actually be approaching a breakup point.
Intercept Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Intercept Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Intercept Pharmaceuticals is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Cardiff Oncology and Intercept Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cardiff Oncology and Intercept Pharmaceuticals

The main advantage of trading using opposite Cardiff Oncology and Intercept Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cardiff Oncology position performs unexpectedly, Intercept Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Intercept Pharmaceuticals will offset losses from the drop in Intercept Pharmaceuticals' long position.
The idea behind Cardiff Oncology and Intercept Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Other Complementary Tools

Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios